Market Analysis: Global Microarray Instruments and Reagents Market
Market Definition: Global Microarray Instruments and Reagents Market
Microarray instruments and reagents are the components based on life-science based laboratory research studies designed for the detection of gene expressions in a significantly large volume consecutively. These instruments are reagents are used for implementing DNA microarray or protein microarray which essentially means that the scientists are provided with thousands of DNA spots in pre-specified positions of microscopic slides which are commonly known as DNA sequence.
Get More Insights About Global Microarray Instruments and Reagents Market, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-microarray-instruments-and-reagents-market
Growing volume of population suffering from various long-term chronic illnesses; this factor is expected to boost the growth of the market
Presence of various easy-to-use standardization along with easy accessibility of technology and products; this factor is expected to drive the growth of the market
Cost-efficient features of microarrays is another factor uplifting the market growth
Increasing areas of applications associated with microarray technology will also foster the market growth
Absence/dearth of technically skilled professionals; this factor is expected to act as a restraint to the growth of the market
Various innovations and technological advancements associated with next-generation sequencing will restrict this market growth
Segmentation: Global Microarray Instruments and Reagents Market
Research & Academic Institutes
Pharmaceutical & Biotechnology Companies
Rest of Europe
Rest of Asia-Pacific
Rest of South America
Middle East and Africa
Rest of Middle East and Africa
Know more about this report https://www.databridgemarketresearch.com/reports/global-microarray-instruments-and-reagents-market
Key Developments in the Market:
In December 2017, PerkinElmer Inc. announced that they had completed the acquisition of EUROIMMUN Medical Laboratory Diagnostics AG. This acquisition will significantly enhance the levels of expertise and capabilities of PerkinElmer for autoimmune testing and other diagnostic procedures. The transaction was completed for an approximate amount of USD 1.3 billion
In September 2017, Agilent Technologies, Inc. announced that they had received U.S. FDA 510(k) clearance for their “GenetiSure Dx Postnatal Assay”. This assay is designed to enhance the capabilities of scientists regarding the detection of irregularities, and intellectual disabilities in a more resource-efficient manner as compared to conventional technologies
Key Market Competitors:
Few of the major competitors currently working in the global microarray instruments and reagents market are Thermo Fisher Scientific Inc.; Agilent Technologies, Inc.; Illumina, Inc.; PerkinElmer Inc.; Merck KGaA; Molecular Devices, LLC; Microarrays Inc.; Bio-Rad Laboratories, Inc.; Applied Micro Arrays; Luminex Corporation among others.
Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.
Request for Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-microarray-instruments-and-reagents-market
Browse Trending Related Reports @
About Data Bridge Market Research: